Secretion from acinar cells of the exocrine pancreas: Role of enteropancreatic reflexes and cholecystokinin

Cell Biology International

Volumn 33, Issue 1, 2009, Pages 1-9

  Singer, Manfred V ^a   Niebergall Roth, Elke ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; PANCREAS ENZYME;

ACINAR CELL; BRAIN STEM; CELL SECRETION; CHOLINERGIC SYSTEM; DUODENUM MUCOSA; EFFERENT NERVE; FOOD INTAKE; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS; MOTONEURON NUCLEUS; NONHUMAN; PANCREAS SECRETION; PARACRINE SIGNALING; POSTGANGLIONIC NERVE; PREGANGLIONIC NERVE CELL; PROTEIN EXPRESSION; REVIEW; VAGUS NERVE NUCLEUS; VAGUS REFLEX;

ANIMALS; CHOLECYSTOKININ; DOGS; GUINEA PIGS; HUMANS; MICE; PANCREAS, EXOCRINE; PIPERIDINES; PIRENZEPINE; RATS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; RECEPTORS, CHOLECYSTOKININ; REFLEX; VAGUS NERVE;

CANIS FAMILIARIS; RATTUS;

EID: 57649173548     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.09.008     Document Type: Review

References (80)

1. Adler G., Beglinger C., Braun U., Reinshagen M., Koop I., Schafmayer A., et al. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 100 (1991) 537-743
2. Anagnostides A.A., Chadwick V.S., Selden A.C., Bart J., and Maton P.N. Human pancreatic and biliary responses to physiological concentrations of cholecystokinin octapeptide. Clin Sci 69 (1985) 259-263
3. Beglinger C., Hildebrand P., Adler G., Werth B., Luo H., Delco F., et al. Postprandial control of gallbladder contraction and exocrine pancreatic secretion. Eur J Clin Invest 22 (1992) 827-834
4. Beinborn M., Lee Y.M., McBride E.W., Quinn S.M., and Kopin A.S. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 362 (1993) 348-350
5. Berthoud H.R., and Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat 156 (1996) 123-131
6. Bi Y., and Williams J.A. Receptor biology and signal transduction in pancreatic acinar cells. Curr Opin Gastroenterol 20 (2004) 427-434
7. Cantor P., Olsen O., Gertz B.J., Gjorup I., and Worning H. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. Scand J Gastroenterol 26 (1991) 627-637
8. Caulfield M.P., and Birdsall N.J.M. International Union of Pharmacology. XVII Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 (1998) 279-290
9. Cho S.-J., Quinn A.S., Stromer M.H., Dash S., Cho J., Taatjes D.J., et al. Structure and dynamics of the fusion pore in live cells. Cell Biol Int 26 (2002) 35-42
10. Corp E.S., McQuade J., Moran T.H., and Smith G.P. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res 623 (1993) 161-166
11. Dufresne M., Seva C., and Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev 86 (2006) 805-847
12. Gautam D., Han S.-J., Heard T.S., Cui Y., Miller G., Bloodworth L., and Wess J. Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice. J Pharmacol Exp Ther 313 (2005) 995-1002
13. Gautam D., Duttaroy A., Cui Y., Han S.-J., Deng C., Seeger T., et al. M1-M3 muscarinic acetylcholine receptor-deficient mice. J Mol Neurosci 30 (2006) 157-160
14. Goyal R.K. Muscarinic receptor subtypes. Physiology and clinical implications. N Engl J Med 321 (1989) 1022-1029
15. Fourmy D., Zahidi A., Fabre R., Guidet M., Pradayrol L., and Ribet A. Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. Eur J Biochem 165 (1987) 683-692
16. Fox-Threlkeld J.A., and Daniel E.E. How selective are the cholecystokinin antagonists in the dog?. Gastroenterology 108 (1995) 1953-1955
17. Funakoshi A., Fukamizu Y., and Miyasaka K. Mechanism of cholecystokinin-A receptor antagonist on human pancreatic exocrine secretion. Digestion 60 Suppl. 1 (1999) 75-80
18. Holtmann G., Küppers U., and SingerTelenzepine M.V. a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs. Scand J Gastroenterol 25 (1990) 293-297
19. Jaworek J., and Konturek S.J. Effects of pirenzepine and atropine on amylase response to various secretagogues from the rat pancreatic acini. Digestion 36 (1987) 175-181
20. Jena B.P. Molecular machinery and mechanism of cell secretion. Exp Biol Med 230 (2005) 307-319
21. Jena B.P. Secretion machinery at the cell plasma membrane. Curr Opin Struct Biol 17 (2007) 437-443
22. Jena B.P., Cho S.J., Jeremic A., Stromer M.H., and Abu-Hamdah R. Structure and composition of the fusion pore. Biophys J 84 (2003) 1-7
23. Jeremic A., Kelly M., Cho S.J., Stromer M.H., and Jena B.P. Reconstituted fusion pore. Biophys J 85 (2003) 2035-2043
24. Ji B., Bi Y., Simeone D., Mortensen R.M., and Logsdon C.D. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121 (2001) 1380-1390
25. Ji B., Bi Y., Simeone D., Mortensen R.M., and Logsdon C.D. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol Toxicol 91 (2002) 327-332
26. Kerstens P.J., Lamers C.B., Jansen J.B., de Jong A.J., Hessels M., and Hefkenscheid J.C. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Life Sci 36 (1985) 565-569
27. Kirchgessner A.L., and Gershon M.D. Innervation and regulation of the pancreas by neurons in the gut. Z Gastroenterol 26 (1991) 230-233
28. Konturek S.J., Pepera J., Zabielski K., Konturek P.C., Pawlik T., Szlachcic A., et al. Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 54 (2003) 293-317
29. Konturek S.J., Zabielski R., Kohnturek J.W., and Czarnecki J. Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol 481 (2003) 1-14
30. Ladenheim E.E., Speth R.C., and Ritter P.C. Reduction of CCK-8 binding in the nucleus of the solitary tract in unilaterally nodosectomized rats. Brain Res 414 (1988) 125-129
31. Leja-Szpak A., Jaworek J., Nawrot-Porabka K., Palonek M., Mitis-Musiol M., Dembinski A., et al. Modulation of pancreatic enzyme secretion by melatonin and its precursor l-tryptophan. Role of CCK and afferent nerves. J Physiol Pharmacol 55 Suppl 2 (2004) 33-46
32. Li Y. Sensory signal transduction in the vagal primary afferent neurons. Curr Med Chem 14 (2007) 2554-2563
33. Li Y., and Owyang C. Vagal efferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 92 (1993) 418-424
34. Li Y., and Owyang C. Pancreatic secretion evoked by cholecystokinin- and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibers in the rat. J Physiol 494 (1996) 773-782
35. Li Y., Wu X., Zhu J., Yan J., and Owyang C. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J Physiol 552 (2003) 571-587
36. Londong W., Londong V., Neierl A., and Voderholzer U. Telenzepine is at least 25 times more potent than pirenzepine - a dose response and comparative secretory study in man. Gut 28 (1987) 888-895
37. Louie D.S., and Owyang C. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies. Am J Physiol 251 (1986) G275-G279
38. Love J.A., Eunyoung Y., and Smith T.G. Autonomic pathways regulating pancreatic exocrine secretion. Auton Neurosci 133 (2007) 19-34
39. Kato M., Ohkuma S., Kataoka K., Kashima K., and Kuriyama K. Characterization of muscarinic receptor subtypes on rat pancreatic acini: pharmacological identification by secretory responses and binding studies. Digestion 52 (1992) 194-203
40. Miyasaka K., Shinozaki H., Jimi A., and Funakoshi A. Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin A nor cholecystokinin B receptors mediate amylase secretion in vitro. Pancreas 25 (2002) 161-165
41. Moriarty P., Dimaline R., Thompson D.G., and Dockray G.J. Characterization of cholecystokinin A and cholecystokinin B receptors expressed by vagal afferent neurons. Neuroscience 79 (1997) 905-913
42. Morton M.F., Pyati J., Dai H., Li L., Moreno V., and Shankley N.P. Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor. Br J Pharmacol 145 (2005) 374-384
43. Nelson D.K., Malfertheiner P., Dahmen G., Dominguez-Munoz J.E., Pieramico O., and Adler G. Regulation of exocrine and endocrine pathways via M1-muscarinic pathways. In: Singer M.V., Ziegler R., and Rohr G. (Eds). Gastrointestinal tract and endocrine system (1995), Kluwer, Dordrecht 570-574
44. Niebergall-Roth E., and Singer M.V. Control of pancreatic exocrine secretion via muscarinic receptors: which subtype(s) are involved?. Pancreatology 3 (2003) 284-292
45. Niebergall-Roth E., and Singer M.V. Enteropancreatic reflexes mediating the pancreatic enzyme response to nutrients. Auton Neurosci 125 (2006) 62-69
46. Niebergall-Roth E., Teyssen S., Wetzel D., Hartel M., Beglinger C., Riepl R.L., et al. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy. Am J Physiol 272 (1997) G1550-G1559
47. Niebergall-Roth E., Teyssen S., Hartel M., Beglinger C., Riepl R.L., and Singer M.V. Pancreatic bicarbonate response to intraduodenal tryptophan in dogs. Role of muscarinic M1-receptors and cholecystokinin. Int J Pancreatol 23 (1998) 31-39
48. Niebergall-Roth E., Teyssen S., and Singer M.V. Blockade of M1 receptors has different effects on endogenously and exogenously stimulated pancreatic protein output in dogs. In: Singer M.V., and Krammer H.-J. (Eds). Neurogastroenterology. From the basics to the clinics (2000), Kluwer, Dordrecht 389-393
49. Niebergall-Roth E., Teyssen S., and Singer M.V. Effects of M1 and CCK antagonists on latency of pancreatic amylase response to intestinal stimulants. Am J Physiol 279 (2000) G411-G416
50. Owyang C., and Logsdon C.D. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 127 (2004) 957-969
51. O'Rourke M.F., Reidelberger R.D., and Solomon T.E. Effects of atropine on pancreatic response to bethanechol, cholecystokinin, and food intake in rats. Am J Physiol 261 (1991) G735-G741
52. Pandol S.J. Neurohormonal control of exocrine pancreatic secretion. Curr Opin Gastroenterol 19 (2003) 443-446
53. Pandol S.J. Neurohormonal control of exocrine pancreatic secretion. Curr Opin Gastroenterol 20 (2004) 435-438
54. Pozo M.J., Estevez M.J., Alcon S., Camello P.J., Pariente J.A., and Salido G.M. Cholinergic dependence of pancreatic response to cholecystokinin in rats and guinea pigs. Gen Pharmacol 26 (1995) 843-850
55. Reeve J.R., Green G.M., Chew P., Eysselein V.E., and Keire D.A. CCK8 is the only detectable endocrine form of cholecystokinin in rats. Am J Physiol Gastrointest Liver Physiol 285 (2003) G255-G265
56. Reeve J.R., Liddle R.A., McVey D.C., Vigna S.R., Solomon T.E., Keire D.A., et al. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties. Am J Physiol Gastrointest Liver Physiol 287 (2004) G326-G333
57. Rehfeld J.F., Friis-Hansen L., Goetze J.P., and Hansen V.O. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem 7 (2007) 1154-1165
58. Reubi J.C., Waser B., Gugger M., Friess H., Kleeff J., Kayed H., et al. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. Gastroenterology 1265 (2003) 98-106
59. Richards W., Hillsley K., Eastwood C., and Grundy D. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. J Physiol 497 (1996) 473-481
60. Rogers R.C., Hermann G.E., and Travagli R.A. Brainstem control of gastric function. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract (2006), Academic Press, San Diego, CA 851-875
61. Schmid S.W., Modlin I.M., Tang L.H., Stoch A., Rhee S., Nathanson M.H., et al. Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells. Am J Physiol 274 (1998) G734-G741
62. Schudt C., Boer R., Eltze M., Riedel R., Grundler G., and Birdsall N.J. The affinity, selectivity and biological activity of telenzepine enantiomers. Eur J Pharmacol 165 (1989) 87-96
63. Schneider S.W., Sritharan K.C., Geibel J.P., Oberleithner H., and Jena B.P. Surface dynamics in living acinar cells imaged by atomic force microscopy: identification of plasma membrane structures involved in exocytosis. Proc Natl Acad Sci U S A 94 (1997) 316-321
64. Schwartz G.J., and Moran T.H. CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann N Y Acad Sci 713 (1994) 121-128
65. Singer M.V. Neurohormonal control of the pancreatic enzyme secretion in animals. In: Go V.L.W. (Ed). The pancreas: biology, pathobiology, and diseases (1993), Raven, New York 425-448
66. Singer M.V., Solomon T.E., Wood J., and Grossman M.I. Latency of pancreatic enzyme response to intraduodenal stimulants. Am J Physiol Gastrointest Liver Physiol 238 (1980) G23-G29
67. Singer M.V., Niebel W., Jansen J.B.M.J., Hoffmeister D., Gotthold S., Goebell H., et al. Pancreatic secretory response to intravenous caerulein and intraduodenal tryptophan: studies before and after stepwise removal of the extrinsic nerves of the pancreas in dogs. Gastroenterology 96 (1989) 925-934
68. Singer M.V., Teyssen S., and Küppers U. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs. Digestion 48 (1991) 34-42
69. Solomon T.E. Control of exocrine pancreatic secretion. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract (1994), Raven, New York 1499-1529
70. Soudah H.C., Lu Y., Hasler W.L., and Owyang C. Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 263 (1992) 827-834
71. Takiguchi S., Suzuki S., Sato Y., Kanai S., Miyasaka K., Jimi A., et al. Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice. Pancreas 24 (2002) 276-283
72. Turner D.J., Cowles R.A., Segura B.J., and Mulholland M.W. Cholinergic stimulation of rat acinar cells increases c-fos and c-jun expression via a mitogen-activated protein kinase-dependent pathway. Gastroinest Surg 6 (2001) 661-672
73. Vazquez-Echarri J., Baumgärtner D., and Singer M.V. Dose-reponse effects of atropine on pancreatic secretory response to intestinal tryptophan in dogs. Am J Physiol 251 (1986) G847-G851
74. Vazquez-Echarri J., Baumgärtner D., and Singer M.V. Dose-response effects of atropine on pancreatic secretory response to intravenous caerulein in dogs. Pancreas 1 (1986) 341-346
75. Viard E., Zheng Z., Was S., and Travagli R.A. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion. Am J Physiol Gastrointest Liver Physiol 293 (2007) G493-G500
76. Waelbroek M., Camus J., Winand J., and Christophe J. Different antagonist binding on rat pancreatic and cardiac muscarinic receptors. Life Sci 41 (1987) 2235-2240
77. Wan S., Coleman F.H., and Travagli R.A. Cholecystokinin-8s excites rat pancreatic-projecting vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 293 (2007) G484-G492
78. Wang B.J., and Cui Z.J. How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol 292 (2007) R666-R678
79. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44 (2004) 423-450
80. Yamamoto M., Otani M., Jia D.-M., Fukumitsu K.-I., Yoshikawa H., Akiyama T., et al. Differential mechanism and site of action on the pancreatic secretion and growth in rats. Am J Physiol Gastrointest Liver Physiol 285 (2003) G681-G687